)
Keming Zhou
Senior Director and Head of siRNA Therapeutics,
Qilu Pharmaceuticals
Enthusiastic and dedicated scientist and industrial leader with experience of leading drug discovery from target identification, nomination and validation to selection and optimization of pre-clinical candidates. More than 16-years of post-graduate experience specializing in investigating molecular mechanisms and exploring innovative therapies, including ASOs, siRNA. With background in RNA-targeting therapies, including efficacy, toxicity, PK/PD, I have worked on neurological, ocular diseases, muscular diseases and liver-targeting indications.